The European Medicine Agency (EMA) advises against use of COVID-19 Vaccine Janssen in people with history of capillary leak syndrome.
EMA’s safety committee (
) has recommended that people who have previously had capillary leak syndrome must not be vaccinated with
COVID-19 Vaccine Janssen
. The Committee also recommended that capillary leak syndrome should be added to the
as a new side effect of the vaccine, together with a warning to raise awareness among healthcare professionals and patients of this risk.